This website is about the chemotherapy medication pemetrexed. It is also called LY231514. Pemetrexed is a drug that belongs to a class of ...
Easy to read patient leaflet for pemetrexed. Includes indications, proper use, special instructions, precautions, and possible side effects.
Learn how ALIMTA may help treat advanced nonsquamous non-small cell lung cancer (NSCLC). Find information about taking ALIMTA for the treatment of advanced NS NSCLC.
History. The molecular structure of pemetrexed was developed by Edward C. Taylor at Princeton University and clinically developed by Indianapolis based drug maker ...
(pem-a-trex-ed) Trade names: Alimta ® Alimta is the trade name for the generic drug name Pemetrexed. In some cases, health care professionals may use the trade name ...
FDA Approval for Pemetrexed Disodium. Use in Cancer. Pemetrexed disodium is approved to be used alone or with other drugs to treat: Malignant pleural mesothelioma in ...
Learn about the prescription medication Alimta (Pemetrexed), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling.
Pemetrexed. On October 17, 2012, the U. S. Food and Drug Administration expanded labeling to include the results of an additional trial evaluating the safety and ...
Find out more about pemtrexed (alimta ®), a chemotherapy drug used to treat non-small cell lung cancer and pleural mesothelioma
Alimta, pemetrexed for injection, is a white to either light-yellow or green-yellow lyophilized powder available in sterile single-use vials containing 100 mg or 500 ...